Axsome Therapeutics, Inc. (AXSM) Social Stream



Axsome Therapeutics, Inc. (AXSM): $69.45

-0.35 (-0.50%)

POWR Rating

Component Grades

Momentum

B

Stability

F

Sentiment

Quality

C

Add AXSM to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#93 of 167

in industry

AXSOME THERAPEUTICS INC (AXSM) Price Targets From Analysts

Use the tables below to see what analysts covering AXSOME THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 12 $180 $34 $98.272 $69.8 40.79%
2021-12-17 11 $180 $34 $98.272 $69.8 40.79%
2021-12-20 11 $180 $26 $95.727 $69.8 37.14%
2022-03-02 11 $180 $26 $89.363 $69.8 28.03%
2022-03-07 11 $180 $31 $88.454 $69.8 26.72%
2022-03-29 11 $180 $31 $89.909 $69.8 28.81%
2022-04-21 11 $180 $34 $90.454 $69.8 29.59%
2022-04-25 11 $180 $34 $90.272 $69.8 29.33%
2022-04-27 11 $180 $27 $88.181 $69.8 26.33%
2022-05-03 11 $180 $27 $87.181 $69.8 24.9%
2022-06-02 10 $180 $27 $84.1 $69.8 20.49%
2022-07-11 10 $180 $28 $89.4 $69.8 28.08%
2022-08-10 10 $180 $28 $89.5 $69.8 28.22%
2022-08-13 10 $180 $28 $87.1 $69.8 24.79%
2022-08-21 10 $180 $34 $90.6 $69.8 29.8%
2022-08-23 10 $180 $34 $101.5 $69.8 45.42%
2022-09-02 10 $210 $34 $106.5 $69.8 52.58%
2022-09-17 11 $210 $34 $109.2 $69.8 56.45%
2022-10-04 11 $210 $34 $108.1 $69.8 54.87%
2022-10-13 12 $210 $34 $108.4 $69.8 55.3%
2022-10-24 12 $210 $35 $104.272 $69.8 49.39%
2022-11-04 13 $210 $35 $103.5 $69.8 48.28%
2022-11-08 13 $210 $35 $103.416 $69.8 48.16%
2022-11-09 13 $210 $35 $103.75 $69.8 48.64%
2022-11-18 13 $210 $34 $105 $69.8 50.43%
2022-11-28 13 $210 $35 $105.083 $69.8 50.55%
2022-11-29 13 $210 $52 $109.916 $69.8 57.47%
2023-01-03 14 $210 $52 $109 $69.8 56.16%
2023-01-26 15 $210 $52 $106.571 $69.8 52.68%
2023-02-14 15 $210 $52 $107 $69.8 53.3%
2023-02-28 15 $210 $52 $107.357 $69.8 53.81%
2023-03-13 15 $210 $52 $107.857 $69.8 54.52%
2023-03-20 15 $200 $52 $107.142 $69.8 53.5%
2023-04-05 15 $200 $52 $106.785 $69.8 52.99%
2023-04-17 15 $200 $52 $106.642 $69.8 52.78%
2023-04-27 15 $200 $52 $105.2 $69.8 50.72%
2023-05-09 15 $200 $57 $105.533 $69.8 51.19%
2023-05-10 15 $200 $57 $107.5 $69.8 54.01%
2023-05-23 15 $200 $57 $109 $69.8 56.16%

The Trend in the Analyst Price Target


Over the past 14 months, AXSM's average price target has gone up $19.09.

Over the past 51 weeks, AXSM's average upside potential has been 84.11%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-02 10 180 27 86.636 24.78 249.62%
2022-09-10 11 210 34 109.200 62.07 75.93%
2022-11-07 13 210 35 103.416 56.82 82.01%
2022-11-08 13 210 35 103.416 63.46 62.96%
2023-04-27 15 200 52 105.200 71.16 47.84%

AXSM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.47 12 0 2 0 0 15

The Trend in the Broker Recommendations


Over the past 26 weeks, AXSM's average broker recommendation rating worsened by 0.09.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how AXSOME THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -4232.07% of that group.
  • AXSM has a higher number of analysts covering the stock than 3894.65% of stocks in the mid market cap category.
  • AXSOME THERAPEUTICS INC's average analyst price target is higher than 3853.81% of stocks in the mid market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AXSOME THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1188.05% of them.

Stocks similar to AXSOME THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BPMC, MCRB, and ASND.

Is AXSM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.817 seconds.